A recombinant adenovirus with deleted E1 and E3, and E4-mouse livers from days 3 to 28. Ten weeks after injection, inactivated by replacing the E4 promoter with a synthetic p53 gene expression was still detected in G4-treated promoter composed of a minimal TATA box and five con-C57BL/6 mice at similar levels, but was not detectable in sensus yeast GAL4-binding site elements was developed WT-treated mice. Vector-induced liver toxicity was evaluand used to express the human tumor suppresser gene ated by analyzing serum transaminases (SGOT and p53. The toxicity and immunogenicity of this vector and SGPT) activities. In all cases, SGOT and SGPT activities vector-mediated p53 gene expression in vivo were studied were markedly decreased in EG-treated C3H and C57BL/6 in immunocompetent C3H and C57BL/6 mice. Expression mice compared with those in EW-treated mice on days 3, of the late viral gene product, hexon protein, was observed 7 and 14 after injection. In C57BL/6 mice, the total antiin C3H and C57BL/6 mice injected with E4 wild-type adenoviral CTL activities were two-to three-fold higher in adenovirus constructs Adv-cmv--Gal (BG), Adv-cmv-hp53 animals treated with EW vector than in those treated with (WT), and empty E1 − vector Adv-E4 (EW) 3 to 28 days EG vector. These results suggest that inactivation of the after injection, but was undetectable in mice treated with E4 promoter efficiently diminished the viral replication and E4 modified empty E1 − vector Adv-GAL4 (EG) or Adv-cmvthe late viral gene expression, reduced host immune hp53-GAL4 (G4). Expression of the p53 gene was response and consequently reduced toxicity and prolonged observed in both WT-and G4-injected C3H and C57BL/6 the duration of transgene expression in vivo.